From CBC News:
Health Canada has revised prescribing information for the medication Rituxan after some people taking the drug for non-Hodgkin's lymphoma developed potentially life-threatening bowel obstruction or bowel perforation.
Rituxan is approved for use in Canada to treat non-Hodgkin's lymphoma (a cancer of the lymph nodes) and rheumatoid arthritis.
The drug's manufacturer, Hoffmann-LaRoche, said there have been two cases of bowel obstruction, including one death, and two cases of bowel perforation related to the use of Rituxan in Canada. ...more
Links to the latest news in the world of pharmacy with a focus on items most relevant to Canadian pharmacists or others that are interested in Canadian pharmacies. This includes news about Canadian pharmacy seen in the mainstream media on topics such as new drug information and the international pharmacy industry.
Tuesday, November 14, 2006
Drug Rituxan linked to bowel problems, Health Canada advises
Here is some additional info about the Rituxan advisory...
No comments:
Post a Comment